Literature DB >> 33526975

Minimally invasive surgery for patients with advanced stage endometrial cancer.

Sang Il Kim1, Dong Choon Park1, Sung Jong Lee2, Ji Geun Yoo3, Min Jong Song4, Chan Joo Kim5, Hae Nam Lee6, Joo Hee Yoon1.   

Abstract

Objective: Compare the oncologic outcomes of patients with advanced stage endometrial cancer who were staged by minimally invasive surgery with the outcomes of patients who underwent open surgery.
Methods: Data from 138 patients with advanced stage endometrial cancer who were treated between January 2009 and January 2019 were reviewed. The patients' data were retrieved from five institutions. The patients were divided into two groups: those who underwent open surgery and those who underwent minimally invasive surgery. Tumor characteristics, recurrence rate, disease-free survival, and overall survival were compared according to surgical approach.
Results: Among the 138 patients included in this study, 72 underwent open surgery (52.2%) and 66 underwent MIS (47.8%). In patients with advanced-stage endometrial cancer, the recurrence rate was significantly higher among those who underwent open surgery (43.1% vs. 25.8%, p = 0.033). Patients with advanced-stage endometrial cancer who underwent open surgery had a significantly lower disease-free survival (p = 0.029) than those who underwent minimally invasive surgery, however, the overall survival (p = 0.051) was similar between the two groups.
Conclusion: Minimally invasive surgery showed better survival outcomes when compared to open surgery in advanced-stage EC patients irrespective of the histologic type. © The author(s).

Entities:  

Keywords:  PORTEC-3; adjuvant treatment; advanced stage; endometrial cancer; minimally invasive surgery

Year:  2021        PMID： 33526975      PMCID： PMC7847628          DOI： 10.7150/ijms.52293

Source DB:  PubMed          Journal:  Int J Med Sci        ISSN： 1449-1907            Impact factor:   3.738


  23 in total

1.  Minimally Invasive Approach in Type II Endometrial Cancer: Is It Wise and Safe?

Authors:  Giorgia Monterossi; Fabio Ghezzi; Enrico Vizza; Gian Franco Zannoni; Stefano Uccella; Giacomo Corrado; Stefano Restaino; Lorena Quagliozzi; Jvan Casarin; Giorgia Dinoi; Giovanni Scambia; Francesco Fanfani
Journal:  J Minim Invasive Gynecol       Date:  2017-01-05       Impact factor: 4.137

2.  Low-risk corpus cancer: is lymphadenectomy or radiotherapy necessary?

Authors:  A Mariani; M J Webb; G L Keeney; M G Haddock; G Calori; K C Podratz
Journal:  Am J Obstet Gynecol       Date:  2000-06       Impact factor: 8.661

Review 3.  Endometrial cancer.

Authors:  Frederic Amant; Philippe Moerman; Patrick Neven; Dirk Timmerman; Erik Van Limbergen; Ignace Vergote
Journal:  Lancet       Date:  2005 Aug 6-12       Impact factor: 79.321

4.  Recurrence and survival after random assignment to laparoscopy versus laparotomy for comprehensive surgical staging of uterine cancer: Gynecologic Oncology Group LAP2 Study.

Authors:  Joan L Walker; Marion R Piedmonte; Nick M Spirtos; Scott M Eisenkop; John B Schlaerth; Robert S Mannel; Richard Barakat; Michael L Pearl; Sudarshan K Sharma
Journal:  J Clin Oncol       Date:  2012-01-30       Impact factor: 44.544

5.  Laparoscopy versus laparotomy in endometrial cancer: first analysis of survival of a randomized prospective study.

Authors:  Roberto Tozzi; Sabine Malur; Christhardt Koehler; Achim Schneider
Journal:  J Minim Invasive Gynecol       Date:  2005 Mar-Apr       Impact factor: 4.137

6.  Effect of Total Laparoscopic Hysterectomy vs Total Abdominal Hysterectomy on Disease-Free Survival Among Women With Stage I Endometrial Cancer: A Randomized Clinical Trial.

Authors:  Monika Janda; Val Gebski; Lucy C Davies; Peta Forder; Alison Brand; Russell Hogg; Thomas W Jobling; Russell Land; Tom Manolitsas; Marcelo Nascimento; Deborah Neesham; James L Nicklin; Martin K Oehler; Geoff Otton; Lewis Perrin; Stuart Salfinger; Ian Hammond; Yee Leung; Peter Sykes; Hextan Ngan; Andrea Garrett; Michael Laney; Tong Yow Ng; Karfai Tam; Karen Chan; C David Wrede; Selvan Pather; Bryony Simcock; Rhonda Farrell; Gregory Robertson; Graeme Walker; Nigel R Armfield; Nick Graves; Anthony J McCartney; Andreas Obermair
Journal:  JAMA       Date:  2017-03-28       Impact factor: 56.272

7.  Long-term oncological safety of minimally invasive surgery in high-risk endometrial cancer.

Authors:  Martin Koskas; Marta Jozwiak; Marie Fournier; Ignace Vergote; Hans Trum; Christianne Lok; Frédéric Amant
Journal:  Eur J Cancer       Date:  2016-08-06       Impact factor: 9.162

8.  Combined laparoscopic and vaginal surgery for the management of two cases of stage I endometrial cancer.

Authors:  J M Childers; E A Surwit
Journal:  Gynecol Oncol       Date:  1992-04       Impact factor: 5.482

9.  ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up.

Authors:  N Colombo; C Creutzberg; F Amant; T Bosse; A González-Martín; J Ledermann; C Marth; R Nout; D Querleu; M R Mirza; C Sessa
Journal:  Ann Oncol       Date:  2015-12-02       Impact factor: 32.976

10.  Prediction of Cancer Incidence and Mortality in Korea, 2020.

Authors:  Kyu-Won Jung; Young-Joo Won; Seri Hong; Hyun-Joo Kong; Eun Sook Lee
Journal:  Cancer Res Treat       Date:  2020-03-16       Impact factor: 4.679
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.